Altium Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-75,000	Closed	-$6.26M	–	72
2024 Q4	$6.26M	Sell	75,000 -79,000	-51%	-$6.49M	1.78%	18
2024 Q3	$11.3M	Sell	154,000 -39,000	-20%	-$2.93M	3.32%	7
2024 Q2	$13.2M	Buy	193,000 +80,000	+71%	+$5.55M	5.39%	4
2024 Q1	$7.82M	Buy	113,000 +42,000	+59%	+$2.89M	3.09%	11
2023 Q4	$5.09M	Buy	71,000 +43,000	+154%	+$2.47M	3.45%	12
2023 Q3	$1.46M	Buy	+28,000	New	+$1.63M	0.76%	30
2023 Q1	–	Sell	-100,000	Closed	-$5.29M	–	115
2022 Q4	$5.29M	Hold	100,000	–	–	2.69%	9
2022 Q3	$4.65M	Buy	100,000 +25,000	+33%	+$1.31M	1.71%	12
2022 Q2	$4.28M	Buy	75,000 +52,500	+233%	+$2.98M	1.71%	14
2022 Q1	$1.38M	Buy	+22,500	New	+$1.17M	0.46%	69
2021 Q2	–	Sell	-88,326	Closed	-$3M	–	160
2021 Q1	$3M	Sell	88,326 -65,022	-42%	-$2.26M	0.83%	50
2020 Q4	$4.88M	Buy	+153,348	New	+$4.03M	1.82%	13